NEWS

Noema Pharma Hosting Key Opinion Leader Webinar on Stuttering

BASEL, Switzerland, December 8, 2021 – Noema Pharma, a Swiss-based clinical stage company targeting orphan central nervous system (CNS) diseases, today announced that it will …

Noema Pharma expands its Board of Directors with the appointments of Catherine Moukheibir and Ilise Lombardo

BASEL, Switzerland, November 9, 2021 – Noema Pharma, a Swiss-based clinical stage company targeting orphan central nervous system (CNS) diseases, today announces the appointment of …

Noema Pharma appoints Jeffrey Jonas as Independent Chairman of the Board of Directors

BASEL, Switzerland, October 4, 2021 –Noema Pharma AG, a Swiss-based clinical stage company targeting orphan central nervous system (CNS) diseases, today announces the appointment of …